All In Biotech

Drug Trial Radar · NCT03738215

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

A Double-Blind, Placebo-Controlled Study of Cariprazine as an Adjunct to Antidepressants in the Treatment of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to Antidepressants Alone

Last checked: Nov 20, 2026Latest source record: Oct 25, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 759 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

759

Actual

Start

Nov 9, 2018

Primary completion

Sep 30, 2021

Study completion Sep 30, 2021

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Nov 13, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate the efficacy, safety and tolerability of cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD who have had an inadequate response to antidepressants alone.

Conditions

  • Major Depressive Disorder

Interventions

  • CariprazineDrug

    Cariprazine supplied in capsules

  • PlaceboDrug

    Placebo supplied in capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total Score Change From Baseline to Week 6 in the MADRS (Montgomery-Åsberg Depression Rating Scale)Time frame: Baseline and Week 6

Locations

125 sites in 7 countries. Site status is shown where the registry gives one.

  • Alea Research /ID# 234789

    Phoenix, Arizona

  • Atria Clinical Research /ID# 237988

    Little Rock, Arkansas

  • Woodland Research Northwest, LLC /ID# 236641

    Rogers, Arkansas

  • California Pharmaceutical Research Institute /ID# 236732

    Anaheim, California

  • Advanced Research Center /ID# 237957

    Anaheim, California

  • Axiom Research /ID# 236268

    Colton, California

  • ATP Clinical Research, Inc /ID# 236619

    Costa Mesa, California

  • ProScience Research Group /ID# 236442

    Culver City, California

  • Collaborative Neuroscience Research - Orange County /ID# 237639

    Garden Grove, California

  • Irvine Clinical Research /ID# 237409

    Irvine, California

  • Omega Clinical Trials LLC /ID# 238168

    La Habra, California

  • Synergy San Diego /ID# 236654

    Lemon Grove, California

  • Anderson Clinical Research /ID# 236627

    Redlands, California

  • Sharp Mesa Vista Hospital /ID# 235797

    San Diego, California

  • Viking Clinical Research /ID# 236614

    Temecula, California

  • Olympian Clinical Research /ID# 237417

    Clearwater, Florida

  • MD Clinical

    Hallandale, Florida

  • Reliable Clinical Research /ID# 234786

    Hialeah, Florida

  • CNS Healthcare - Jacksonville /ID# 238241

    Jacksonville, Florida

  • Space Coast Neuropsychiatric Research Institute /ID# 235765

    Palm Bay, Florida

  • University of South Florida /ID# 234386

    Tampa, Florida

  • Institute for Advanced Medical Research /ID# 236672

    Alpharetta, Georgia

  • iResearch Atlanta, LLC /ID# 237389

    Decatur, Georgia

  • Psych Atlanta /ID# 235835

    Marietta, Georgia

  • Capstone Clinical Research /ID# 236546

    Libertyville, Illinois

  • Pillar Clinical Research /ID# 235702

    Lincolnwood, Illinois

  • NeuroPsychiatric Research Practice & Associate LTD /ID# 234636

    Winfield, Illinois

  • Lake Charles Clinical Trials /ID# 237723

    Lake Charles, Louisiana

  • J. Gary Booker MD APMC /ID# 234514

    Shreveport, Louisiana

  • Pharmasite Research, Inc. /ID# 237395

    Baltimore, Maryland

  • CBH Health LLC /ID# 234536

    Gaithersburg, Maryland

  • Michigan Clinical Research Institute /ID# 234792

    Ann Arbor, Michigan

  • NeuroBehavioral Medicine Group /ID# 236671

    Bloomfield Hills, Michigan

  • Precise Research Centers /ID# 236598

    Flowood, Mississippi

  • Millennium Psychiatric Associates LLC /ID# 235989

    St Louis, Missouri

  • Alivation Research /ID# 236583

    Lincoln, Nebraska

  • Altea Research Institute /ID# 236726

    Las Vegas, Nevada

  • Hassman Research Institute /ID# 237501

    Berlin, New Jersey

  • Integrative Clinical Trials /ID# 236656

    Brooklyn, New York

  • Manhattan Behavioral Medicine PLLC /ID# 236314

    New York, New York

Showing 40 of 125 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.